Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well gossypol works in treating patients with progressive
or recurrent glioblastoma multiforme. Gossypol may stop the growth of tumor cells by blocking
some of the enzymes needed for cell growth.